to common dm care challenges
play

To Common DM Care Challenges Paul Aoun, D.O., Ph.D. Clinical - PowerPoint PPT Presentation

Effective Solutions To Common DM Care Challenges Paul Aoun, D.O., Ph.D. Clinical endocrinologist, PBDES Affiliate Assistant Professor, Univ Miami Disclosure Speaker for Astra-Zeneca I do not have any financial relationships relative to


  1. Effective Solutions To Common DM Care Challenges Paul Aoun, D.O., Ph.D. Clinical endocrinologist, PBDES Affiliate Assistant Professor, Univ Miami

  2. Disclosure • Speaker for Astra-Zeneca • I do not have any financial relationships relative to the content of this program

  3. In 1980: 108 Million Adults had diabetes

  4. Prevalence of Diabetes and Prediabetes in the United States 140 Undiagnosed DM Diagnosed DM 120 Prediabetes 8.1 Diabetes 7 Persons (millions) 100 21.0 9.1% of US population 18.8 80 5.7 17.9 60 Prediabetes 86 40 79 37% of US population 57 20 0 2007 1 2011 2 2014 3 1. CDC. National diabetes fact sheet, 2008. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2008.pdf. 2. CDC. National diabetes fact sheet, 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf. 4 3. CDC. National diabetes statistics report, 2014. http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf

  5. HOW ARE WE DOING?

  6. A1C Achievement by Individualized Target NHANES 2007-2010 (N=1444) 100 90 Patients with diabetes (%) 74.6 80 69.4 70 57.1 57.1 60 52.0 50 39.4 37.0 40 30 20 10 0 Age (years) 18-44 45-64 ≥65 ≥65 18-44 45-64 ≥65 Target A1C (%) ≤6.5 ≤7.0 ≤7.0 ≤7.5 ≤7.0 ≤8.0 ≤8.0 Without complications With complications NHANES, National Health and Nutrition Examination Survey. 10 Ali MK, et al. N Engl J Med . 2013;368:1613-1624.

  7. WHY?

  8. 1 in 3 MEDICARE $ People with Diagnosed Diabetes ADA AACE

  9. S. 586/H.R. 1192

  10. Are 50%+ not reaching Treatment goals AND/OR Are we NOT reaching them?

  11. Are novel therapies needed AND/OR Need to make better use of existing modalities?

  12. OBJECTIVES The 4 Cs to improve Diabetes care outcomes

  13. OBJECTIVES The First “C”

  14. Is it Compliance??

  15. Compliance Concordance COMPREHENSION -Diabetes - Patient’s preference -Treatment: -Set of values Dietary choices -Living conditions Physical Activity -Socioeconomic status Medications -Psychosocial barriers -Ramifications

  16. OBJECTIVES: The First �C� -Comprehension • Diabetes • Treatment: – Dietary choices – Physical Activity – Medications

  17. The First “C” -Comprehension Why do you think you developed diabetes?

  18. The genes set the stage, the behavior tells the tale…

  19. OBJECTIVES: The First �C� -Comprehension • Diabetes • Treatment: – Dietary choices – Physical Activity – Medications

  20. Almost all diets (and diet pills) work initially Almost all diets (and diet pills) fail eventually

  21. As A Medical Community: We Must Aim for Long-Lasting SUSTAINABLE Results

  22. Portion Control & Restrict refined carbs and simple sugars

  23. Mayo Clinic

  24. Total Calories : 350 vs. 1400 Mayo Clinic

  25. 200 calories WiseGeek.com

  26. NUTRITION HEALTH = CALORIES Furhman, J 2003

  27. Physical Activity Altering the perception

  28. Physical Activity Exercise

  29. • Exercise: a structured form of activity for a defined purpose, often to compete in a sport or strength-training to maintain a certain fitness level. • Physical activity: Any bodily movement that involves muscle contraction.

  30. James A .Levine, 2007

  31. James A .Levine, 2007

  32. OBJECTIVES: The First �C� -Comprehension • Diabetes • Treatment: – Dietary choices – Physical Activity – Medications

  33. Comprehension: Incentive You are _____ lbs away from coming off _____________

  34. Simplicity Improves Adherence

  35. OBJECTIVES the 4Cs -Comprehension -Complexity

  36. CASE-1 • 72 y.o. F Medically-complicated obesity (BMI 36); DM-2 since 1982; HTN; Dyslipidemia, CKD (eGFR-60s) • Was on Metf, believes stopped due to CKD and changed to insulin only 10-15 yrs prior • New consultation early 2015 for DM-2: A1C 8.6%; Cr-1.0; BMI-36 • Glargine 34 HS; Lispro up to 28 ac TID • Lives w/ husband who assists with insulin administration & treatment of hypoglycemia • �frustrated� w/ BG variability and hypos

  37. CASE-1 BASELINE: Glargine 34 HS; Lispro up to 28 ac TID PROGRESS: -Added Metformin; Reduced Insulin requirements by 40%; lost 8 lbs -Added GLP-1A (Transient), stopped Prandial insulin (Lispro); lost addt’l 10 lbs, reduced GLP-1A dose -C-pep; GAD; ICAs all reassuring: Stopped GLP-1A (Fall 2015); Changed basal insulin to Glim 2 mg ½ AM and one tab PM -By late 2015, off all insulin, on Metf+Glim. Stable CKD

  38. A1C-8.6% A1C-6.5% Wt: 188 lbs Wt: 164 lbs

  39. Simplicity improves adherence • AVOID OVERINSULINIZATION – Revisit the need for insulin – Minimize/eliminate complex regimens, ESPECIALLY IN THE ELDERLY

  40. Effects of Wt loss on B-cell parameters Insulin Sensitivity Insulin Secretion Obese non-DM Obese Diabetics Kelley DE et al, JCEM 1993 Ferrannini E et al, Diabetes 2004 Robertson SP et al, Diabetes 2004

  41. • B cell failure: – Dysfunction (“stunned”) – De-differentiation – Death? Halban PA et al. JCEM 2014

  42. • “Interestingly, the greatest HbA 1c reduction was the fall of 2% during the first 3 months with intensive diet and 5% weight loss” R. Holman, Oxford, U.K (Chief Investigator-UKPDS)

  43. Simplicity improves adherence • AVOID OVERINSULINIZIATION – Revisit the need for insulin – Minimize/eliminate complex regimens, ESPECIALLY IN THE ELDERLY • Minimize OADs associated with HYPOGLYCEMIA

  44. Meds associated with Hypoglycemia • LOWmeperide • LOWpizide • LOWburide

  45. OBJECTIVES the 4Cs -Comprehension -Complexity -Cost

  46. Medscape, 2016

  47. COST Medscape, 2016

  48. Treat-to-target Trial Riddle MC et al, Diabetes Care , 2003

  49. Treat-to-target Trial 6.9% vs 4% events per pt-yr Riddle MC et al, Diabetes Care , 2003

  50. LANMET Study Jarvinen YH et al, Diabetologia , 2006

  51. LANMET Study WKS 0-12 13-24 25-36 Jarvinen YH et al, Diabetologia , 2006

  52. LANMET Study Jarvinen YH et al, Diabetologia , 2006

  53. NPH B L D HS B

  54. Cost • If insulin indicated, Basal+Metformin or other OADs often sufficient • REINTRODUCE METFORMIN: whenever feasible

  55. FDA & Metformin

  56. DESIGN & FINDINGS • MEDLINE and Cochrane databases search for English- language articles pertaining to metformin, kidney disease, and lactic acidosis in humans between 1950 and June 2014. • 65/818 articles met criteria • FINDINGS: Estimated incidence of LA similar to those not treated with Metformin

  57. Phenformin Metformin

  58. Phenformin’s lactogenic effect >140x Metformin. 2 1. Tahrani AA et al. BMJ. 2007;335(7618):508-12 2. Wang DS et al. Mol Pharmacol 2003

  59. OBJECTIVES the 4Cs -Comprehension -Complexity -Cost -Connotation

  60. Positive Connotation “To me, marketing is about values” Steve Jobs

  61. Positive Connotation “Who knows the most, lives the longest” (and lives the best) Elliott P Joslin

  62. VALUES CONNOTATION COMPREHENSION COST COMPLEXITY EBM

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend